Clinical indication and timing of antenatal corticosteroid administration at a single centre

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 3, 2016, Pages 409-414

  Levin, H I ^a   Ananth, C V ^a,b   Benjamin Boamah, C ^a   Siddiq, Z ^a   Son, M ^a   Friedman, A M ^a  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

Author keywords

Antenatal corticosteroid administration; care quality; preterm delivery

Indexed keywords

CORTICOSTEROID; FIBRONECTIN;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; COHORT ANALYSIS; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OUTCOME ASSESSMENT; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL CARE; PRENATAL PERIOD; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; INFANT, PREMATURE, DISEASES; PREGNANCY; TIME FACTOR;

ADRENAL CORTEX HORMONES; ADULT; COHORT STUDIES; FEMALE; HUMANS; INFANT, PREMATURE, DISEASES; PREGNANCY; PRENATAL CARE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84956768504     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13730     Document Type: Article

References (14)

1. Roberts D, Dalziel S,. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; CD004454.
2. Sinclair JC,. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol 1995; 173: 335-44.
3. Liggins GC, Howie RN,. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-25.
4. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994; 12: 1-24.
5. Ring AM, Garland JS, Stafeil BR, Carr MH, Peckman GS, Pircon RA,. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007; 196: 457 e1-6.
6. Peaceman AM, Bajaj K, Kumar P, Grobman WA,. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005; 193: 1165-9.
7. McEvoy C, Schilling D, Spitale P, Peters D, O'Malley J, Durand M,. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy. Pediatrics 2008; 121: e1032-8.
8. Waters TP, Mercer B,. Impact of timing of antenatal corticosteroid exposure on neonatal outcomes. J Matern Fetal Neonatal Med 2009; 22: 311-4.
9. Razaz N, Skoll A, Fahey J, Allen VM, Joseph KS,. Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis. Obstet Gynecol 2015; 125: 288-96.
10. Goldenberg RL, Culhane JF, Iams JD, Romero R,. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
11. Garite TJ, Kurtzman J, Maurel K, Clark R, Obstetrix Collaborative Research Network. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009; 200: 248 e1-9.
12. Crowther CA, McKinlay CJ, Middleton P, Harding JE,. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2011;(6): CD003935.
13. Chandrasekaran S, Srinivas SK,. Antenatal corticosteroid administration: understanding its use as an obstetric quality metric. Am J Obstet Gynecol 2014; 210: 143.e1-7.
14. Adams TM, Kinzler WL, Chavez MR, Fazzari MJ, Vintzileos AM,. Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity. J Matern Fetal Neonatal Med 2015; 28: 1598-601.